Category: AXN

3rd Quarter 2017 – Growth Portfolio Update

3rd Quarter 2017 – Growth Portfolio Update

AXN – As mentioned in the recent Aoxing Pharmaceutical blog, I ended my position in this stock as the company announced a delisting of their common stock. The remaining proceeds have been reinvested into 22nd Century Group and TransEnterix Inc. OBCI – Continuing to hold steady in this growth stock as it tracks towards $6.…

Read More Read More

Aoxing Pharmaceutical Company – AXN

Aoxing Pharmaceutical Company – AXN

The end of the road has been reached for this company! And I have to say, it will not be missed. Today, AXN has announced a deregistration of their common stock and eventual delisting. The main reason for this action gravitating towards the company’s financial woes. So, what are some takeaways? A lack of communication…

Read More Read More